Retatrutide – 10mg Vial
Retatrutide is an experimental investigational peptide currently being studied for its potential effects on weight management and metabolic health. It is a novel triple agonist that acts on the GLP-1, GIP, and glucagon receptors. Early research suggests that Retatrutide may help regulate appetite, improve glucose control, and promote bodyweight reduction through multi-pathway signaling.
Each vial contains 10 mg of lyophilized Retatrutide in a sterile, sealed container. This compound is supplied in powder form and is intended for laboratory use in ongoing studies of receptor activity and peptide stability.
⚠️ Disclaimer
This product is sold strictly for research purposes only.
Not for human consumption, medical use, or veterinary use.
Must only be handled by qualified professionals in a controlled laboratory environment.
CanadaPeptides/CanadaPep.ca assumes no liability for misuse or handling outside of approved research settings.